Contact US | Chinese
You Position: Home > Journal issue
Drug Evaluation Drug Evaluation

2023:

2022:

2021:

2020:

2019:

2018:

2017:

2016:

2015:

2014:

2013:

2012:

2011:

2010:

2009:

2008:

2007:

2006:

2005:

2004:

Drug Evaluation

Items 1-5 of 11
«Preious | of 3 |
1

胰高糖素样肽-1受体激动剂周制剂的中国证据

Drug Evaluation, Volume 17, Issue z1,2020, Pages 33-37, doi:10.3969/j.issn.1672-2809.2020.z1.007

2

Real World Evidence for Application of Glucagon-like Peptide-1 Receptor Antagonist in Asian Population

Drug Evaluation, Volume 17, Issue z1,2020, Pages 38-42, doi:10.3969/j.issn.1672-2809.2020.z1.008

3

The Effect of GLP-1 Receptor Agonist safety on Clinical Therapy

Drug Evaluation, Volume 17, Issue z1,2020, Pages 48-52, doi:10.3969/j.issn.1672-2809.2020.z1.010

4

Interpretation of the Latest Guidelines: the Choice of Initial Antihyperglycemic Injection Therapy

Drug Evaluation, Volume 17, Issue z1,2020, Pages 19-22, doi:10.3969/j.issn.1672-2809.2020.z1.004

Items 1-5 of 11
«Preious | of 3 |
WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn